权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Computationally Guided Design of Thermostable mutants of Neurotensin receptor1

神经降压素受体 1 热稳定突变体的计算引导设计

基本信息

批准号：
8084826
负责人：
Nagarajan Vaidehi
金额：
$ 33.6万
依托单位：
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
依托单位国家：
美国
项目类别：
财政年份：
2011
资助国家：
美国
起止时间：
2011-09-01 至 2014-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8084826
关键词：
Adenosine A2A Receptor Adrenergic Receptor Algorithms Binding Biochemical Budgets Calibration Cells Cities Collaborations Computer Simulation Computing Methodologies Crystallization Data Detergents Disease Drug Delivery Systems Drug Design Drug abuse Environment Feedback Functional disorder Funding G-Protein-Coupled Receptors Goals Growth Growth Factor Homology Modeling Hydrogen Bonding In Vitro Interdisciplinary Study Laboratories Ligand Binding Ligands Malignant Neoplasms Marketing Membrane Methods Modeling Molecular Conformation Molecular Structure Mutagenesis Mutation National Institute of Neurological Disorders and Stroke Nature Neurotensin Neurotensin Receptors Peptides Pharmaceutical Preparations Pharmacology Phase Play Point Mutation Potential Energy Process Proteins Rattus Research Personnel Role Sampling Scanning Schizophrenia Side Signal Pathway Solutions Structure Techniques Testing Time United States National Institutes of Health Work base cancer cell cost design experience flexibility improved in vivo inhibitor/antagonist innovation insight interdisciplinary approach interdisciplinary collaboration meetings mimetics mutant protein purification receptor reconstitution research study stem valylleucine

项目摘要

DESCRIPTION (provided by applicant): Neurotensin receptors belong to the superfamily of peptide activated G protein-coupled receptors (GPCRs) and they are important drug targets to diseases such as schizophrenia and even cancer. The complexity in drug design for NTS1 and for many peptide activated GPCRs partly stems from the paucity of structural information, which could provide vital information for rational drug design. The barriers to pursuing structural and biophysical studies of membrane bound neurotensin receptors are due primarily to three challenges that are: 1.obtaining sufficient levels of expressed mammalian receptors, 2. functionally reconstituting them into membrane mimetics and 3. most importantly, stabilizing a particular inactive or active state conformation due to the conformational flexibility of GPCRs. While steps (1) and (2) are surmountable, step (3) the conformational flexibility in GPCRs, severely hampers the protein purification process for further crystallization or any other biophysical studies of GPCRs. Therefore meeting challenge (3) is critical in solving the macromolecular structure and ligand binding to GPCRs and requires a confluence of predictive computational models accompanied by experimental techniques. We propose to develop a computational method "LiticonDesign" that would enable design of thermally stable mutants of rat neurotensin receptor 1 (NTS1) (class A GPCRs in general). LiticonDesign will be based on the "Liticon", a predictive method that allows accurate modeling of various functional ligand stabilized conformational states of GPCRs. The predicted mutants of NTS1 will be expressed and tested for thermal stability and derive sufficient quantities of the pure functional receptor for structural studies. The results of this proposed work will provide a breakthrough method to obtain stable and functional pure protein of NTS1 which could be extended to other class A GPCRs. The proposed interdisciplinary collaboration is between Dr. Nagarajan Vaidehi (PI) at City of Hope, Dr. Reinhard Grisshammer NINDS/NIH and Dr. Christopher Tate (Univ. of Cambridge UK). Dr. Vaidehi has extensive experience in developing modeling techniques for GPCRs, while Dr. Tate is an expert in deriving thermostable mutants of GPCRs. Dr. Grisshammer is an expert on neurotensin receptors and their pharmacology. The budget is allocated only for Dr. Vaidehi, since Dr. Grisshammer is funded by the intramural funding in NINDS and Dr. Tate has sufficient funding for this work. The proposed work is ongoing in his laboratory. PUBLIC HEALTH RELEVANCE: The neurotensin receptor1, NTS1 plays an important role in the pathophysiology of schizophrenia and drug abuse. The peptide neurotensin, acts as a growth factor on cancer cells and NTS1 antagonists such as SR48692 have been suggested to prove useful as inhibitors of NT-induced cancer growth. The proposed interdisciplinary research will develop computational methods to design thermally stable mutants of NTS1 that would enable purification of sufficient quantities of stable and functional NTS1 in detergents. The resulting mutants will be experimentally made and tested for thermal stability in detergents. The results of this study will pave way to further biophysical and structural studies of NTS1, which is sparse at best.

描述（由申请人提供）：神经降压素受体属于肽活化G蛋白偶联受体（GPCR）的超家族，并且它们是诸如精神分裂症甚至癌症的疾病的重要药物靶标。NTS 1和许多肽激活的GPCR的药物设计的复杂性部分源于结构信息的缺乏，这可以为合理的药物设计提供重要信息。对膜结合神经降压素受体进行结构和生物物理学研究的障碍主要是由于三个挑战：1.获得足够水平的表达的哺乳动物受体，2.将它们功能性地重建成膜模拟物，以及3.最重要的是，由于GPCR的构象灵活性，稳定了特定的非活性或活性状态构象。虽然步骤（1）和（2）是可克服的，但步骤（3）GPCR中的构象灵活性严重阻碍了用于进一步结晶或GPCR的任何其他生物物理研究的蛋白质纯化过程。因此，满足挑战（3）对于解决大分子结构和配体与GPCR的结合是至关重要的，并且需要预测计算模型与实验技术的融合。我们建议开发一种计算方法“LiticonDesign”，这将使设计大鼠神经降压素受体1（NTS 1）的热稳定突变体（一般为A类GPCR）成为可能。LiticonDesign将基于“Liticon”，这是一种预测方法，可以准确建模GPCR的各种功能配体稳定的构象状态。NTS 1的预测突变体将被表达并测试热稳定性，并获得足够量的纯功能受体用于结构研究。本研究结果为获得稳定的、功能性的NTS 1蛋白提供了一种突破性的方法，并可推广到其他A类GPCR中。拟议的跨学科合作是在City of Hope的Nagarajan Vaidehi博士（PI），Reinhard Grisshammer NINDS/NIH博士和Christopher Tate博士（英国剑桥大学）之间。Vaidehi博士在开发GPCR建模技术方面拥有丰富的经验，而Tate博士则是推导GPCR热稳定突变体的专家。Grisshammer博士是神经降压素受体及其药理学方面的专家。预算只分配给Vaidehi博士，因为Grisshammer博士是由NINDS的内部资金资助的，Tate博士有足够的资金从事这项工作。这项工作正在他的实验室进行。公共卫生相关性：神经降压素受体1（NTS 1）在精神分裂症和药物滥用的病理生理学中起着重要作用。肽神经降压素作为癌细胞的生长因子，并且NTS 1拮抗剂如SR 48692已被证明可用作NT诱导的癌症生长的抑制剂。拟议的跨学科研究将开发计算方法来设计NTS 1的热稳定突变体，从而能够在洗涤剂中纯化足够数量的稳定和功能性NTS 1。将通过实验制备所得突变体并测试其在洗涤剂中的热稳定性。这项研究的结果将为NTS 1的进一步生物物理和结构研究铺平道路，NTS 1充其量是稀疏的。